Patent details

Herbas

VPB

Print

EN | LT

LT - USE OF RESLIZUMAB TO TREAT MODERATE TO SEVERE EOSINOPHILIC ASTHMA

EN - USE OF RESLIZUMAB TO TREAT MODERATE TO SEVERE EOSINOPHILIC ASTHMA

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	C07K 16/24

European patent
(11)	Number of the document	3191513
(13)	Kind of document	T
(96)	European patent application number	15760590.8
	Date of filing the European patent application	2015-08-28
(97)	Date of publication of the European application	2017-07-19
(45)	Date of publication and mention of the grant of the patent	2020-06-24
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/US2015/047357
	Date	2015-08-28

PCT application publication
(87)	Number	WO 2016/040007
	Date	2016-03-17

Priority applications
(30)	Number	Date	Country code
	201462047248 P	2014-09-08	US
	201462091150 P	2014-12-12	US
	201562168007 P	2015-05-29	US
	201562191690 P	2015-07-13	US

Inventors
(72)	BRUSSELLE, Guy, BE O`BRIEN, Christopher, US ZANGRILLI, James, US SHAH, Tushar, US

Grantee
(73)	Cephalon, Inc., 41 Moores Road P.O. Box 4011, Frazer, PA 19355, US

Title
(54)	USE OF RESLIZUMAB TO TREAT MODERATE TO SEVERE EOSINOPHILIC ASTHMA
	USE OF RESLIZUMAB TO TREAT MODERATE TO SEVERE EOSINOPHILIC ASTHMA